For decades, scientists have known that infection with the Epstein-Barr virus (EBV) is one of the strongest risk factors for developing multiple sclerosis (MS). But an important question has remained: How does a virus carried by more than 90 per cent of adults contribute to a disease that affects only a small fraction of people? A new review led by Dr. Jan Lünemann, UBC Chair in Multiple Sclerosis and Autoimmune Neurology Research and Director…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.